Internet and Telephone Counseling for Smoking Cessation
OBJECTIVES:
- Compare the efficacy of premium internet intervention vs premium internet with
telephone intervention vs basic internet intervention, as determined by 7-day point
prevalence abstinence at 12 months, in adult smokers.
- Compare the cost-effectiveness of these interventions in promoting smoking cessation.
- Determine the effects of internet-based interventions on measured use of the
intervention (frequency and duration of use, utilization of behavioral coping, expert
advices, and e-mail) in these patients.
- Determine the effects of internet-based interventions on variables important for
behavior change including mediators (e.g., self-efficacy, use of internet social
support) and moderators (e.g., gender, baseline motivation) of outcomes in these
patients.
OUTLINE: This is a randomized, controlled, multicenter study. Patients are stratified
according to gender and baseline motivation level. Patients are randomized to 1 of 3
intervention arms.
- Arm I (basic internet program): Patients are directed to a website of existing QuitNetâ„¢
smoking cessation materials. These materials are not tailored and have no interactive
features.
- Arm II (premium internet program): Patients receive free 6-month access to the QuitNetâ„¢
website including interactive and individualized intervention features.
- Arm III (premium internet program plus telephone counseling): Patients receive free
access to the QuitNetâ„¢ website as in arm II. Patients also receive up to 5 telephone
counseling sessions, scheduled at their convenience.
All patients are assessed at baseline and then at 3, 6, 12, and 18 months.
PROJECTED ACCRUAL: A total of 2,205 patients will be accrued for this study.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Smoking abstinence as measured by 7-day point prevalence abstinence at 12 months following treatment
12 months
No
Amanda L. Graham, PhD
Principal Investigator
Lombardi Cancer Research Center
United States: Food and Drug Administration
CDR0000465179
NCT00282009
August 2004
December 2014
Name | Location |
---|---|
Brown University School of Medicine | Providence, Rhode Island 02905 |